U.S. Industrials Stock News

Sila Realty Trust, Inc. reported past fourth-quarter and full-year 2025 results showing higher revenue of US$50.7 million for the quarter and US$197.54 million for the year, but lower net income of US$5.02 million and US$33.12 million respectively, while funds from operations reached US$30.4 million in Q4 and US$120.9 million for 2025. Alongside these earnings, the board approved a US$0.40 per-share quarterly dividend and highlighted high occupancy, strong lease retention, and active...

Claritev Corporation recently reported past fourth-quarter 2025 sales of US$246.55 million and a net loss of US$80.57 million, alongside full-year 2025 sales of US$965.41 million and a net loss of US$284.28 million, and announced a new share repurchase program of up to US$75 million running through 2030. While the company remains loss-making, the year-on-year reduction in losses and the commitment to buying back shares suggest management is focused on improving financial discipline and...

Perdoceo Education (PRDO) drew fresh attention after reporting fourth quarter and full year 2025 earnings, issuing new 2026 guidance, and affirming its quarterly dividend, giving investors several data points to reassess the stock. See our latest analysis for Perdoceo Education. The recent earnings, 2026 guidance and dividend affirmation come after a period of steady share price strength, with a 90 day share price return of 19.83% and a 1 year total shareholder return of 32.10% supporting a...

Without a specific news announcement driving attention today, United Community Banks (UCB) still offers investors concrete data points to consider, including recent share performance, profitability metrics, and value-focused scores. See our latest analysis for United Community Banks. At a share price of $32.17, United Community Banks has seen a 6.56% 1 month share price decline, while its 90 day share price return of 3.91% and 1 year total shareholder return of 3.10% point to relatively...

Glaukos (GKOS) is back in focus after its fourth quarter 2025 report paired strong sales figures with a sizeable impairment charge, followed shortly by fresh 2026 sales guidance and a new ESOP related shelf registration. See our latest analysis for Glaukos. The recent impairment charge and ESOP related shelf registration come against a backdrop of steady share price gains, with a 90 day share price return of 13.28% and a very large 3 year total shareholder return of 139.03%. This suggests...

Xeris Biopharma recently filed a Hatch-Waxman patent infringement lawsuit in the US District Court for the District of New Jersey against Torrent Pharmaceuticals and Somerset Therapeutics, seeking to block generic versions of its Cushing’s syndrome therapy Recorlev until its patents expire in March 2040. This legal move highlights how central Recorlev’s intellectual property protection is to Xeris’s long-term product exclusivity and potential revenue longevity in its endocrine...

Why Sealed Air is on investors’ radar today Sealed Air (SEE) is back in focus after recent trading left the shares around $41.88, prompting investors to reassess how its packaging business and current valuation line up with their expectations. See our latest analysis for Sealed Air. While the 1-day and 7-day share price returns are slightly negative, Sealed Air’s 1-year total shareholder return of 25.46% contrasts with weaker 3-year and modest 5-year total shareholder returns, which suggests...

EyePoint, Inc. recently appointed Michael Campbell as Chief Commercial Officer, giving him responsibility for commercial strategy and launch preparation for DURAVYU, its Phase 3 retinal disease candidate. The hire brings in a leader who helped shape the commercial playbooks behind Lucentis, Xiidra, Beovu and Tyrvaya, directly relevant to DURAVYU’s target markets. We’ll now examine how adding a veteran ophthalmology launch executive to oversee DURAVYU’s commercialization may influence...

Emerson Electric (EMR) is back on investors’ radar after its Q1 2026 earnings report and a higher full year EPS forecast, with management pointing to electrification and nearshoring as key demand drivers. See our latest analysis for Emerson Electric. The Q1 earnings beat and raised EPS guidance arrived after a strong run, with a 90 day share price return of 14.26% and a 1 year total shareholder return of 26.02%, suggesting momentum has been building over both shorter and longer periods. If...

ATRenew (RERE) is back in focus after recent coverage highlighted revenue growth of 22% and earnings expanding more than fourfold, as investors look ahead to its March 11, 2026 unaudited 2025 results release. See our latest analysis for ATRenew. That backdrop helps explain why investor sentiment has shifted, with a 90 day share price return of 26.42% and a 1 year total shareholder return of 104.59%. This comes even though the latest 1 day move was a 3.34% share price decline to US$5.79,...

Omnicell has recently accelerated its shift from hardware-focused sales toward software and services, including acquiring ANiGENT in October 2025 to broaden its drug diversion detection capabilities and recurring revenue base. This pivot toward subscription-like revenue streams is prompting investors to reassess Omnicell less as a traditional equipment maker and more as a healthcare IT provider, with different expectations for growth, risk and valuation. Next, we’ll examine how Omnicell’s...

In Q4 2025, Harbor Capital Advisors' Mid Cap Value Fund disclosed that it had initiated a new position in EnerSys, citing improving operating margins, sales growth, strong cash flow, ongoing share buybacks, and regular dividend payments as key reasons for the investment. The fund also ranked EnerSys in the top 5% of its evaluation universe, highlighting how the company’s combination of operating momentum and capital returns screens well against a broad mid-cap peer group. Next, we’ll examine...

Recent commentary around MGM Resorts International (MGM) has focused on its aggressive share repurchases, the expanding BetMGM digital gaming footprint, and a series of catalysts that include asset sales, the Las Vegas recovery, and the planned Osaka integrated resort. See our latest analysis for MGM Resorts International. At a share price of $36.86, MGM’s recent 30 day share price return of 9.90% contrasts with a 1 year total shareholder return of 6.04% and a 3 year total shareholder loss of...

Valley National Bancorp (VLY) shares dropped 6.2% as hotter inflation data and growing credit risk worries pressured regional lenders, even though the bank confirmed regular dividends and a new share repurchase authorization. See our latest analysis for Valley National Bancorp. Despite the latest 5.7% one day share price decline to US$12.61, Valley National Bancorp’s 90 day share price return of 9.8% and 1 year total shareholder return of 34.0% suggest momentum has generally been positive...

Arcosa (ACA) is back on investors’ radar after a recent share pullback over the past week and month, drawing attention to how its infrastructure focused business and current valuation metrics stack up today. See our latest analysis for Arcosa. The sharp 1 day share price decline of 15.7% and 7 day share price return of 14.9% sit against a 1 year total shareholder return of 28.42% and 5 year total shareholder return of 84.39%. This suggests recent momentum has cooled after a strong multi year...

In February 2026, Ladder Capital Corp. announced it had secured US$675 million in new unsecured capital commitments, expanding its unsecured revolving credit facility to US$1.25 billion and adding a US$275 million unsecured delayed draw term loan priced at 140 basis points over SOFR. This package of same-day liquidity at 125 basis points over SOFR and long-dated funding to 2030 materially strengthens Ladder’s funding flexibility and duration profile. Next, we’ll examine how this expanded...

Fourth quarter earnings and capital returns in focus OneSpaWorld Holdings (OSW) reported its fourth quarter and full year 2025 results, with higher revenue and slightly lower net income, alongside fresh revenue guidance, a quarterly dividend, increased impairments and a completed share buyback tranche. See our latest analysis for OneSpaWorld Holdings. The earnings release, dividend affirmation and completed share buyback came after a choppy period for the share price, with a 1 month share...

BETA Technologies (BETA) has drawn fresh attention after a recent pullback, with the stock showing negative returns over the past month and past 3 months while the business continues to report rapid annual revenue growth. See our latest analysis for BETA Technologies. The latest pullback has extended BETA Technologies' year to date share price return to a 31.21% decline, with the 90 day share price return of 31.06% pointing to fading momentum despite a flat 7 day move and recent revenue...

In February 2026, Sanofi and Teva Pharmaceutical Industries reported that duvakitug, an investigational TL1A-targeting antibody, achieved durable 44-week clinical and endoscopic efficacy with consistent safety in ulcerative colitis and Crohn’s disease responders in the RELIEVE UCCD long-term extension study. A separate recent milestone saw the US FDA accept Teva’s New Drug Application for TEV-749, a once-monthly olanzapine injection for adult schizophrenia, underscoring the company’s push...

FedEx has filed a lawsuit against the US government seeking reimbursement of tariffs that were ruled invalid by the Supreme Court. The company has pledged to return any recovered tariff funds to affected shippers and consumers. The move has triggered class-action lawsuits from customers and drawn political scrutiny over how potential multibillion dollar tariff refunds will be handled. For investors watching NYSE:FDX, this legal push comes at a time when the stock trades around $387.0 and...

Omnicom Group (NYSE:OMC) is acquiring Interpublic and combining the two global advertising groups into a single company. The company plans to accelerate divestitures of noncore and underperforming businesses as part of the integration. Management is targeting substantial cost synergies, including significant workforce reductions across the combined group. Omnicom has authorized a $5b share repurchase program alongside the integration and restructuring efforts. Omnicom Group, listed on the...

Regency Centers completed a public offering of $450 million in senior unsecured notes due 2033. The issuance is intended to support balance sheet optimization and ongoing development activities. The company trades on the NasdaqGS under the ticker NasdaqGS:REG, with a current share price of $79.0. For investors watching NasdaqGS:REG, this $450 million notes offering is a fresh data point on how Regency Centers is managing its capital structure. The stock is at $79.0, with returns of 2.8%...

If you are wondering whether NVR at around US$7,517.79 is giving you fair value or asking too much, you are not alone. This article is built to answer that question head on. Over shorter periods the stock has been relatively muted, with a 0.8% decline over the last 7 days and a 1.5% decline over the last 30 days, while the return over the last year sits at 3.8% and the 3 year and 5 year returns are 43.3% and 62.6% respectively. Recent coverage around NVR has focused on its position in the US...

LPL Financial Holdings (LPLA) has drawn attention after a period of weaker share performance, with returns over the past month, past 3 months, and year all in negative territory, even though multi year total returns remain positive. See our latest analysis for LPL Financial Holdings. The recent 1 month share price return of a 17.59% decline and year to date share price return of a 16.94% decline point to fading near term momentum, even though the 5 year total shareholder return of 129.88%...